Annual Total Long Term Liabilities
$113.52 M
-$4.98 M-4.20%
December 31, 2023
Summary
- As of February 8, 2025, MRNS annual total long term liabilities is $113.52 million, with the most recent change of -$4.98 million (-4.20%) on December 31, 2023.
- During the last 3 years, MRNS annual total long term liabilities has risen by +$110.98 million (+4379.83%).
- MRNS annual total long term liabilities is now -4.20% below its all-time high of $118.50 million, reached on December 31, 2022.
Performance
MRNS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$95.86 M
-$2.70 M-2.74%
September 30, 2024
Summary
- As of February 8, 2025, MRNS quarterly total long term liabilities is $95.86 million, with the most recent change of -$2.70 million (-2.74%) on September 30, 2024.
- Over the past year, MRNS quarterly long term liabilities has stayed the same.
- MRNS quarterly long term liabilities is now -20.26% below its all-time high of $120.22 million, reached on March 31, 2023.
Performance
MRNS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MRNS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.2% | 0.0% |
| 3 y3 years | +4379.8% | -19.1% |
| 5 y5 years | +100.0% | -19.1% |
MRNS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +165.3% | -20.3% | +124.0% |
| 5 y | 5-year | -4.2% | +4379.8% | -20.3% | +3887.5% |
| alltime | all time | -4.2% | -100.0% | -20.3% | -100.0% |
Marinus Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $95.86 M(-2.7%) |
| Jun 2024 | - | $98.56 M(-11.2%) |
| Mar 2024 | - | $111.03 M(-2.2%) |
| Dec 2023 | $113.52 M(-4.2%) | $113.52 M(-1.9%) |
| Sep 2023 | - | $115.71 M(-2.2%) |
| Jun 2023 | - | $118.26 M(-1.6%) |
| Mar 2023 | - | $120.22 M(+1.4%) |
| Dec 2022 | $118.50 M(+176.9%) | $118.50 M(+44.9%) |
| Sep 2022 | - | $81.79 M(+0.4%) |
| Jun 2022 | - | $81.46 M(+0.7%) |
| Mar 2022 | - | $80.87 M(+89.0%) |
| Dec 2021 | $42.79 M(+1588.6%) | $42.79 M(+0.2%) |
| Sep 2021 | - | $42.70 M(+222.6%) |
| Jun 2021 | - | $13.24 M(+450.6%) |
| Mar 2021 | - | $2.40 M(-5.1%) |
| Dec 2020 | $2.53 M(-16.7%) | $2.53 M(-4.9%) |
| Sep 2020 | - | $2.66 M(-4.7%) |
| Jun 2020 | - | $2.79 M(-4.3%) |
| Mar 2020 | - | $2.92 M(-4.0%) |
| Dec 2019 | $3.04 M | $3.04 M(-3.7%) |
| Sep 2019 | - | $3.16 M(-0.6%) |
| Jun 2019 | - | $3.18 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $3.20 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $100.00 K(-6.5%) |
| Jun 2018 | - | $107.00 K(-6.1%) |
| Mar 2018 | - | $114.00 K(-5.0%) |
| Dec 2017 | $120.00 K(-93.6%) | $120.00 K(-5.5%) |
| Sep 2017 | - | $127.00 K(-3.8%) |
| Jun 2017 | - | $132.00 K(-86.9%) |
| Mar 2017 | - | $1.01 M(-46.5%) |
| Dec 2016 | $1.88 M(-64.4%) | $1.88 M(-31.8%) |
| Sep 2016 | - | $2.76 M(-24.1%) |
| Jun 2016 | - | $3.64 M(-18.5%) |
| Mar 2016 | - | $4.46 M(-15.6%) |
| Dec 2015 | $5.29 M(-24.6%) | $5.29 M(+19.4%) |
| Sep 2015 | - | $4.43 M(-16.5%) |
| Jun 2015 | - | $5.31 M(-14.0%) |
| Mar 2015 | - | $6.17 M(-12.0%) |
| Dec 2014 | $7.02 M(>+9900.0%) | $7.02 M(+251.0%) |
| Sep 2014 | - | $2.00 M(0.0%) |
| Jun 2014 | - | $2.00 M(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00 | - |
FAQ
- What is Marinus Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Marinus Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Marinus Pharmaceuticals?
- What is Marinus Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Marinus Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of MRNS is $113.52 M
What is the all time high annual total long term liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high annual total long term liabilities is $118.50 M
What is Marinus Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, MRNS annual total long term liabilities has changed by -$4.98 M (-4.20%)
What is Marinus Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of MRNS is $95.86 M
What is the all time high quarterly long term liabilities for Marinus Pharmaceuticals?
Marinus Pharmaceuticals all-time high quarterly total long term liabilities is $120.22 M
What is Marinus Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, MRNS quarterly total long term liabilities has changed by $0.00 (0.00%)